Navigation Links
MEI Pharma Acquires PWT143, A Highly Selective PI3-Kinase Delta Inhibitor
Date:9/10/2013

SAN DIEGO, Sept. 10, 2013 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has acquired exclusive worldwide rights to the investigational drug candidate PWT143 from Pathway Therapeutics, Inc., a privately held pharmaceutical company, for an undisclosed upfront payment with no future milestone or royalty obligations.

(Photo: http://photos.prnewswire.com/prnh/20130910/LA76852-INFO)

(Logo: http://photos.prnewswire.com/prnh/20120628/LA32362LOGO)

In pre-clinical studies, PWT143 has been found to be a potent and highly selective oral inhibitor of phosphatidylinositide 3-kinase (PI3K) delta, a molecular target that has been shown to play a critical role in the proliferation and survival of hematologic cancer cells. MEI Pharma anticipates filing an Investigational New Drug (IND) application for PWT143 by the end of 2014.

"PWT143 is an exciting drug candidate with evidence of improved pre-clinical activity compared to other PI3K delta inhibitors currently in development," said Daniel P. Gold, Ph.D., President and Chief Executive Officer of MEI Pharma. "This acquisition represents another opportunity to expand our oncology drug development pipeline under favorable terms, while growing our footprint in hematologic cancers. We expect that it will take a minimal investment of resources to complete the required pre-clinical studies necessary for IND filing, which will enable us to create additional value while maintaining our focus on executing the Phase II clinical development plan for our lead drug candidate, Pracinostat."

"We are very proud of the discove
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
2. Roche and Inovio Pharmaceuticals partner on Inovios prostate cancer and hepatitis B immunotherapy products
3. UHC to Launch New Specialty Pharmacy Program for Better Continuity of Patient Care, Improved Access to Specialty Pharmaceuticals
4. Pharmaceutical Giants Back Researchers in Unique US Competition
5. Several Market Access Drivers Provide Attractive Opportunities for Multinational Companies in Saudi Arabias Pharmaceutical Market
6. DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China
7. Sunshine Act 2013 Updates: A Checklist for Pharmaceutical Companies to Meet CMS Reporting
8. PDL BioPharma Provides Third Quarter 2013 Revenue Guidance of $97 Million
9. Biogen Idec and Isis Pharmaceuticals Announce Strategic Collaboration to Advance Treatment of Neurological Disorders
10. Altaire Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 9 lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution sold under several brands
11. SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Astex Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015 The North American dental ... is estimated to reach $90.7 million by 2019, at a ... through the TOC of North America Dental Lasers Market for ... of various tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ... this report.   Dental lasers are specifically ...
(Date:5/22/2015)... PRUSSIA, Pa. , May 22, 2015  The ... its 2015 Corporate Leadership Award as recognition for the ... the care of the bleeding disorders community.  The award was ... CSL Limited, during the NHF Annual Spring Soiree in ... "The National Hemophilia Foundation is dedicated to finding better ...
(Date:5/22/2015)... May 22, 2015 According to ... by Product (Consumables, Instruments, Services), by Test Type (Indirect, ... Flow Cytometry), by End Users - Global Forecast to ... is expected to reach $736.85 Million by 2020 from ... 10.25%. Browse 71 market data Tables ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... EL SEGUNDO, Calif., June 23 DaVita Inc., ... diagnosed with chronic kidney,failure and disease (CKD), recently ... workshops that encourage CKD patients to,take control of ... care., (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ), Available ...
... 20 GlaxoSmithKline,(NYSE: GSK ) today announced ... extended the priority review period for PROMACTA(R),(eltrombopag) for ... idiopathic thrombocytopenic purpura, as they require more time,to ... action date has,been extended to September 19, 2008., ...
Cached Medicine Technology:DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education 2DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education 3GSK Update on FDA Review of Promacta(R) (Eltrombopag) 2
(Date:5/25/2015)... A recent report for Mass Live ... died as a direct result of an opiate overdose in ... rise in overdose deaths attributed to prescription opiate medications, and ... care about geography. This issue doesn’t care about race. This ... class.” As the state of Mass. reels from the effects ...
(Date:5/25/2015)... Join Fiona's Soccer Camp at Novato High School's Tibi ... National Player, Fiona O'Sullivan will be on site to run ... coaching style. Fiona has three camps running this summer in ... Lynwood Elmentary School (June 15-19) and Hill Recreation Center (June ... 2015 - 1:00-3:00pm. Bring a Soccer Ball, Cleats and a ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 Decora Preset ... ‘Leviton’ is now available on ‘The Hardware City.’ The product ... has to set a time and the related electronic device ... contacted a representative of the company said, “We are glad ... City.’ Now customers can buy Countdown Timer Switch in just ...
(Date:5/24/2015)... 2015 For people who are keen ... Industry, 2009-2019 Market Research Report would be an useful ... study on the present market scenario of this industry. ... growing Chinese market of this industry. The report summarizes ... of the manufacturers in this industry. The report is ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 The ... ( http://www.testosteronelawsuithub.com/ ) has scheduled its next monthly ... the multidistrict litigation. According to court documents filed ... Illinois, the Conference will be convened on June ... Replacement Therapy Product Liability Litigation - MDL No. ...
Breaking Medicine News(10 mins):Health News:Opioid Deaths Increase by 33 Percent Since 2012 in Mass. 2Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3
... NEW YORK, Jan. 18 In football, ... to snacking during football games, defending,against heartburn ... the game as well., (Listen ... http://media.medialink.com/WebNR.aspx?story=34345 ) Registered journalists can access ...
... 2 men taking the product , , FRIDAY, Jan. 18 ... a dietary supplement appears to have contributed to the ... report. , "There were things on the label that ... product that were not on the label," said study ...
... and only medication approved to reduce both A1C ... Daiichi Sankyo, Inc.,announced today that the United ... (colesevelam HCl) to improve glycemic control,(measured as hemoglobin ... in,combination with metformin, sulfonylureas, or insulin, either alone ...
... Joined by New York City Mayor,Michael Bloomberg, ... Carmona today discussed Lance,s request to the Surgeons ... cancer., "This year alone, 1.4 million Americans ... will likely lose their lives to the disease," ...
... led to aggressive disease in 2 men taking the ... mislabeled over-the-counter product described as a dietary supplement appears ... cancer in two men, researchers report. , "There were ... product, and components in the product that were not ...
... diabetes care improvement at a community-level, WASHINGTON, ... in implementing and evaluating models for improving diabetes ... on Health,(NBCH) announced the recipients of its first ... member coalitions -- intended to support the,initial stages ...
Cached Medicine News:Health News:Mislabeled Supplement Spurred Prostate Cancer: Report 2Health News:Mislabeled Supplement Spurred Prostate Cancer: Report 3Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 2Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 3Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 4Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 5Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 6Health News:Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 7Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 3Health News:Mislabled Supplement Spurred Prostate Cancer: Report 2Health News:Mislabled Supplement Spurred Prostate Cancer: Report 3Health News:National Business Coalition on Health Awards Grants to 14 Coalitions for Diabetes Quality Programs 2Health News:National Business Coalition on Health Awards Grants to 14 Coalitions for Diabetes Quality Programs 3
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
... Spaced, Expandable, Multichannel Pipettor The ... boosts productivity with an industry breakthroughequal tip ... of a slide rod. This innovation allows ... between vessels with different configurations. Adjustable ...
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... Ergonomic Design for Unparalleled Comfort ... it. Notice the balance. Notice the trigger and ... left-handed. Thats because our pipettors are ergonomically designed ... long hours of pipetting. Productivity In The ...
Medicine Products: